Risk of Thrombo-Embolic Events in Ovarian Cancer: Does Bevacizumab Tilt the Scale? A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Thromboembolic events (TEs) are the second cause of death in cancer patients. Two forms of thromboembolic events may arise: arterial, such as ischemic stroke or myocardial infarction; and venous, such as deep vein thrombosis or pulmonary embolism. Bevacizumab is a monoclonal antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Saerens, Michael, De Jaeghere, Emiel A., Kanervo, Heini, Vandemaele, Nele, Denys, Hannelore, Naert, Eline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464807/
https://www.ncbi.nlm.nih.gov/pubmed/34572830
http://dx.doi.org/10.3390/cancers13184603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464807/
https://www.ncbi.nlm.nih.gov/pubmed/34572830
http://dx.doi.org/10.3390/cancers13184603

Ejemplares similares